Development and Quantitative Evaluation of a High-resolution Metabolomics Technology

Overview

Journal Anal Chem

Specialty Chemistry

Date 2014 Jan 14

PMID 24410464

Citations 98

Authors

Xiaojing Liu

Zheng Ser

Jason W Locasale

Affiliations

Soon will be listed here.

Abstract

Recent advances in mass spectrometry have allowed for unprecedented characterization of human metabolism and its contribution to disease. Despite these advances, limitations in metabolomics technology remain. Here, we describe a metabolomics strategy that consolidates several recent improvements in mass spectrometry technology. The platform involves a high-resolution Orbitrap mass spectrometer coupled to faster scanning speeds, allowing for polarity switching and improved ion optics resulting in enhanced sensitivity. When coupled to HILIC chromatography, we are able to quantify over 339 metabolites from an extract of HCT8 cells with a linear range of over 4 orders of magnitude in a single chromatographic run. These metabolites include diverse chemical classes ranging from amino acids to polar lipids. In addition, we also detect over 3000 additional potential metabolites present in mammalian cells. We applied this platform to characterize the metabolome of eight colorectal cancer cell lines and observed both commonalities and heterogeneities across their metabolic profiles when cells are grown in identical conditions. Together these results demonstrate that simultaneous profiling and quantitation of the human metabolome is feasible.

Citing Articles

Multi-Omics Assessment of Puff Volume-Mediated Salivary Biomarkers of Metal Exposure and Oxidative Injury Associated with Electronic Nicotine Delivery Systems.

He X, Meister M, Jeon J, Shinde A, Zhang Q, Chepaitis P Environ Health Perspect. 2025; 133(1):17005.

PMID: 39819025 PMC: 11737583. DOI: 10.1289/EHP14321.

Association of serum metabolites with frailty phenotype and its components: a cross-sectional case-control study.

Shida T, Hatanaka S, Kojima N, Ohta T, Osuka Y, Maruo K Biogerontology. 2024; 26(1):21.

PMID: 39643817 DOI: 10.1007/s10522-024-10166-y.

Morphomics, Survival, and Metabolites in Patients With Metastatic Pancreatic Cancer.

Gunchick V, Brown E, Liu J, Locasale J, Philip P, Wang S JAMA Netw Open. 2024; 7(10):e2440047.

PMID: 39418020 PMC: 11581562. DOI: 10.1001/jamanetworkopen.2024.40047.

Separation of reproductive decline from lifespan extension during methionine restriction.

Wei F, Liu S, Liu J, Sun Y, Allen A, Reid M Nat Aging. 2024; 4(8):1089-1101.

PMID: 39060538 DOI: 10.1038/s43587-024-00674-4.

Targeting glutamine metabolism improves sarcoma response to radiation therapy in vivo.

Patel R, Cooper D, Kadakia K, Allen A, Duan L, Luo L Commun Biol. 2024; 7(1):608.

PMID: 38769385 PMC: 11106276. DOI: 10.1038/s42003-024-06262-x.

References

Ishikawa M, Fujino T, Sakashita H, Morikawa K, Yamamoto T . Kinetic properties and structural characterization of highly purified acetyl-CoA synthetase from bovine heart and tissue distribution of the enzyme in rat tissues. Tohoku J Exp Med. 1995; 175(1):55-67. DOI: 10.1620/tjem.175.55. View

Smith C, Want E, OMaille G, Abagyan R, Siuzdak G . XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006; 78(3):779-87. DOI: 10.1021/ac051437y. View

Pfeiffer C, Fazili Z, McCoy L, Zhang M, Gunter E . Determination of folate vitamers in human serum by stable-isotope-dilution tandem mass spectrometry and comparison with radioassay and microbiologic assay. Clin Chem. 2003; 50(2):423-32. DOI: 10.1373/clinchem.2003.026955. View

Ciccimaro E, Blair I . Stable-isotope dilution LC–MS for quantitative biomarker analysis. Bioanalysis. 2010; 2(2):311-41. PMC: 2843934. DOI: 10.4155/bio.09.185. View

Annesley T . Ion suppression in mass spectrometry. Clin Chem. 2003; 49(7):1041-4. DOI: 10.1373/49.7.1041. View

Shyh-Chang N, Locasale J, Lyssiotis C, Zheng Y, Teo R, Ratanasirintrawoot S . Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science. 2012; 339(6116):222-6. PMC: 3652341. DOI: 10.1126/science.1226603. View

Dettmer K, Aronov P, Hammock B . Mass spectrometry-based metabolomics. Mass Spectrom Rev. 2006; 26(1):51-78. PMC: 1904337. DOI: 10.1002/mas.20108. View

Taylor P . Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem. 2005; 38(4):328-34. DOI: 10.1016/j.clinbiochem.2004.11.007. View

Gallien S, Duriez E, Crone C, Kellmann M, Moehring T, Domon B . Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer. Mol Cell Proteomics. 2012; 11(12):1709-23. PMC: 3518128. DOI: 10.1074/mcp.O112.019802. View

10.

De Livera A, Olshansky M, Speed T . Statistical analysis of metabolomics data. Methods Mol Biol. 2013; 1055:291-307. DOI: 10.1007/978-1-62703-577-4_20. View

11.

Southam A, Payne T, Cooper H, Arvanitis T, Viant M . Dynamic range and mass accuracy of wide-scan direct infusion nanoelectrospray fourier transform ion cyclotron resonance mass spectrometry-based metabolomics increased by the spectral stitching method. Anal Chem. 2007; 79(12):4595-602. DOI: 10.1021/ac062446p. View

12.

Sreekumar A, Poisson L, Rajendiran T, Khan A, Cao Q, Yu J . Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009; 457(7231):910-4. PMC: 2724746. DOI: 10.1038/nature07762. View

13.

Christofk H, Vander Heiden M, Harris M, Ramanathan A, Gerszten R, Wei R . The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008; 452(7184):230-3. DOI: 10.1038/nature06734. View

14.

Denkert C, Budczies J, Kind T, Weichert W, Tablack P, Sehouli J . Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 2006; 66(22):10795-804. DOI: 10.1158/0008-5472.CAN-06-0755. View

15.

Yuan M, Breitkopf S, Yang X, Asara J . A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc. 2012; 7(5):872-81. PMC: 3685491. DOI: 10.1038/nprot.2012.024. View

16.

Fedorova G, Randak T, Lindberg R, Grabic R . Comparison of the quantitative performance of a Q-Exactive high-resolution mass spectrometer with that of a triple quadrupole tandem mass spectrometer for the analysis of illicit drugs in wastewater. Rapid Commun Mass Spectrom. 2013; 27(15):1751-62. DOI: 10.1002/rcm.6628. View

17.

Poulsen J, Madsen C, Young C, Kelstrup C, Grell H, Henriksen P . Comprehensive profiling of proteome changes upon sequential deletion of deubiquitylating enzymes. J Proteomics. 2012; 75(13):3886-97. DOI: 10.1016/j.jprot.2012.04.055. View

18.

Kelstrup C, Young C, Lavallee R, Nielsen M, Olsen J . Optimized fast and sensitive acquisition methods for shotgun proteomics on a quadrupole orbitrap mass spectrometer. J Proteome Res. 2012; 11(6):3487-97. DOI: 10.1021/pr3000249. View

19.

Michalski A, Damoc E, Hauschild J, Lange O, Wieghaus A, Makarov A . Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol Cell Proteomics. 2011; 10(9):M111.011015. PMC: 3284220. DOI: 10.1074/mcp.M111.011015. View

20.

Blasco H, Corcia P, Pradat P, Bocca C, Gordon P, Veyrat-Durebex C . Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry. J Proteome Res. 2013; 12(8):3746-54. DOI: 10.1021/pr400376e. View